A device that analyzes blood levels of prostate-specific antigen (PSA) is one of the first doctor’s-office uses of microfluidics–technology that can manipulate fluids on a chip at microscopic scales. When a cartridge bearing a blood sample is inserted into the tabletop device, an accurate reading can be completed in 15 minutes, helping monitor the health of patients with prostate cancer. The procedure used now involves sending a sample to a lab for analysis, which often takes a day or two. The device received European approval in June.
Credit: Christopher Harting
Product: Claros DX 1
Cost: To be announced in late 2010
Availability: Late 2010 in selected European markets
Other products in this section:
Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.Subscribe today
Years before CRISPR babies, this man was the first to edit human embryos
In 2015, an unknown Chinese scientist edited the DNA of human embryos. It was a step on an inexorable path to designer babies.
Despite CRISPR baby controversy, Harvard University will begin gene-editing sperm
Even as a furious debate broke out in China over gene-edited babies, some scientists in the US are also hoping to improve tomorrow’s children.
Rogue Chinese CRISPR scientist cited US report as his green light
An expert finding from the National Academies of Sciences was He Jiankui’s excuse to edit the DNA of two babies.